DK2188258T3 - Substituerede nikotinamidforbindelser og anvendelser deraf i lægemidler - Google Patents

Substituerede nikotinamidforbindelser og anvendelser deraf i lægemidler

Info

Publication number
DK2188258T3
DK2188258T3 DK08802179.5T DK08802179T DK2188258T3 DK 2188258 T3 DK2188258 T3 DK 2188258T3 DK 08802179 T DK08802179 T DK 08802179T DK 2188258 T3 DK2188258 T3 DK 2188258T3
Authority
DK
Denmark
Prior art keywords
pharmaceuticals
nicotinamide compounds
substituted nicotinamide
substituted
compounds
Prior art date
Application number
DK08802179.5T
Other languages
English (en)
Inventor
Beatrix Merla
Sven Kuehnert
Robert Frank
Dagmar Kaulartz
Wolfgang Schroeder
Gregor Bahrenberg
Klaus Schiene
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Application granted granted Critical
Publication of DK2188258T3 publication Critical patent/DK2188258T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12Antidiuretics, e.g. drugs for diabetes insipidus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK08802179.5T 2007-09-17 2008-09-15 Substituerede nikotinamidforbindelser og anvendelser deraf i lægemidler DK2188258T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007044277A DE102007044277A1 (de) 2007-09-17 2007-09-17 Substituierte Nicotinamid-Verbindungen und deren Verwendung in Arzneimitteln
PCT/EP2008/007633 WO2009036938A1 (de) 2007-09-17 2008-09-15 Substituierte nicotinamid-verbindungen und deren verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
DK2188258T3 true DK2188258T3 (da) 2013-01-14

Family

ID=40347805

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08802179.5T DK2188258T3 (da) 2007-09-17 2008-09-15 Substituerede nikotinamidforbindelser og anvendelser deraf i lægemidler

Country Status (24)

Country Link
US (1) US8084470B2 (da)
EP (1) EP2188258B1 (da)
JP (1) JP5539205B2 (da)
KR (1) KR20100068453A (da)
CN (1) CN101801932A (da)
AR (1) AR068467A1 (da)
BR (1) BRPI0817044A2 (da)
CA (1) CA2699689C (da)
CO (1) CO6260092A2 (da)
CY (1) CY1113551T1 (da)
DE (1) DE102007044277A1 (da)
DK (1) DK2188258T3 (da)
ES (1) ES2400407T3 (da)
HK (1) HK1144422A1 (da)
HR (1) HRP20130166T1 (da)
IL (1) IL204496A (da)
MX (1) MX2010002506A (da)
NZ (1) NZ583684A (da)
PE (1) PE20090652A1 (da)
PL (1) PL2188258T3 (da)
PT (1) PT2188258E (da)
RU (1) RU2489425C2 (da)
SI (1) SI2188258T1 (da)
WO (1) WO2009036938A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI475020B (zh) * 2009-03-12 2015-03-01 The substituted nicotine amide as a KCNQ2 / 3 modifier
AU2011295405B2 (en) * 2010-08-27 2015-01-22 Grünenthal GmbH Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators
MX367623B (es) * 2010-10-20 2019-08-29 Gruenenthal Gmbh 6-amino-nicotinamidas sustituidas como moduladores de kcnq2/3.
FR2968661B1 (fr) * 2010-12-14 2016-01-01 Oreal Procede de depigmentation des matieres keratiniques a l'aide de composes thiopyridinones
WO2014056620A1 (en) * 2012-10-11 2014-04-17 Grünenthal GmbH Treatment and/or prophylaxis of tspo mediated diseases and/or disorders
US9248122B2 (en) 2012-11-28 2016-02-02 Grünenthal GmbH Heteroquinoline-3-carboxamides as KCNQ2/3 modulators
AU2013351550A1 (en) 2012-11-28 2015-07-16 Grünenthal GmbH Specific carboxamides as KCNQ2/3 modulators
WO2018110669A1 (en) 2016-12-15 2018-06-21 Ono Pharmaceutical Co., Ltd. Activator of trek (twik related k+ channels) channels

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6022884A (en) * 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use
GB9919588D0 (en) * 1999-08-18 1999-10-20 Hoechst Schering Agrevo Gmbh Fungicidal compounds
US6855829B2 (en) 2001-02-20 2005-02-15 Bristol-Myers Squibb Company 3-fluoro-2-oxindole modulators of KCNQ potassium channels and use thereof in treating migraine and mechanistically related disease
GB0319793D0 (en) * 2003-08-22 2003-09-24 Lilly Co Eli Pyridinylmorpholine derivatives

Also Published As

Publication number Publication date
IL204496A (en) 2013-02-28
EP2188258A1 (de) 2010-05-26
HK1144422A1 (en) 2011-02-18
AR068467A1 (es) 2009-11-18
RU2010115184A (ru) 2011-10-27
RU2489425C2 (ru) 2013-08-10
MX2010002506A (es) 2010-03-26
DE102007044277A1 (de) 2009-03-19
ES2400407T3 (es) 2013-04-09
KR20100068453A (ko) 2010-06-23
US8084470B2 (en) 2011-12-27
PE20090652A1 (es) 2009-05-28
PT2188258E (pt) 2013-01-23
WO2009036938A1 (de) 2009-03-26
JP5539205B2 (ja) 2014-07-02
SI2188258T1 (sl) 2013-01-31
BRPI0817044A2 (pt) 2015-03-24
CO6260092A2 (es) 2011-03-22
EP2188258B1 (de) 2012-11-28
HRP20130166T1 (hr) 2013-03-31
CY1113551T1 (el) 2016-06-22
CA2699689C (en) 2015-03-24
JP2010539124A (ja) 2010-12-16
US20090076086A1 (en) 2009-03-19
CA2699689A1 (en) 2009-03-26
CN101801932A (zh) 2010-08-11
PL2188258T3 (pl) 2013-04-30
AU2008300945A1 (en) 2009-03-26
NZ583684A (en) 2011-04-29

Similar Documents

Publication Publication Date Title
NL300891I2 (nl) Lotilaner en zouten daarvan
CY2015013I2 (el) Αντι-μολυσματικες πυραμιδινες και χρησεις αυτων
DK2185164T3 (da) Sammensætning og terapeutisk antitumorvaccine
DK1894567T3 (da) Ledsagende farmaceutiske midler og anvendelse deraf
DK2147096T3 (da) Modificerede faktor-VII-polypeptider og anvendelser deraf
DK2170827T3 (da) Indolin-2-oner og aza-indolin-2-oner
DK2220320T3 (da) Forseglet enhed og mellemstykke
DK3338790T3 (da) Oligopeptid-forbindelser og anvendelser deraf
DK2012773T3 (da) Lægemidler og anvendelser deraf
BRPI0819573A2 (pt) Composição e artigo
NO20085030L (no) Pyrrolopyrimidinforbindelser og deres anvendelser
DK2231614T3 (da) Quinolinderivativer og anvendelse af disse som fungicider
NO20091424L (no) Substituerte amider, fremgangsmåte for fremstilling derav og anvendelse derav
BRPI0817890A2 (pt) Folha e artigo
DK2234985T3 (da) 4-(4-cyano-2-thioaryl)-dihydropyrimidinoner og deres anvendelse
DK2114924T3 (da) Co-krystaller og farmaceutiske sammensætninger omfattende disse
ATE489389T1 (de) 2 -heteroaryl- pyrrolo ä3, 4-cüpyrrol- derivate und deren verwendung als scd inhibitoren
DK2376791T3 (da) Afstandsindretning og fastgørelsesindretning med afstandsindretning
DK2001556T3 (da) Thioninium-forbindelser og anvendelse deraf
DK2142529T3 (da) Trpv1-antagonister og anvendelser deraf
DK2207773T3 (da) Heterocyklisk forbindelse og farmaceutisk sammensætning deraf.
DK2158199T3 (da) Piperidinforbindelser og anvendelser deraf
DK2245032T3 (da) Folater, sammensætninger og anvendelser deraf
DK2154966T3 (da) Benzimidazoler og farmaceutiske sammensætninger deraf
DK2188258T3 (da) Substituerede nikotinamidforbindelser og anvendelser deraf i lægemidler